Your browser doesn't support javascript.
loading
Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma.
Kudo, Kai; Miki, Yoshimi; Carreras, Joaquim; Nakayama, Shunya; Nakamoto, Yasushi; Ito, Masatoshi; Nagashima, Etsuko; Yamamoto, Kei; Higuchi, Hiroshi; Morita, Shin-Ya; Inoue, Asuka; Aoki, Junken; Ando, Kiyoshi; Nakamura, Naoya; Murakami, Makoto; Kotani, Ai.
Afiliação
  • Kudo K; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan; Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Miki Y; Laboratory of Microenvironmental Metabolic Health Sciences Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Carreras J; Department of Pathology, Tokai University School of Medicine, Isehara, Japan.
  • Nakayama S; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan; Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Nakamoto Y; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan; Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Ito M; Support Center for Medical Research and Education, Tokai University School of Medicine, Isehara, Japan.
  • Nagashima E; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan; Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Yamamoto K; Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan.
  • Higuchi H; Center for Cancer Immunology, Cutaneous Biology Research Center, Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Morita SY; Department of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Japan.
  • Inoue A; Department of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Aoki J; Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan.
  • Ando K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Nakamura N; Department of Pathology, Tokai University School of Medicine, Isehara, Japan.
  • Murakami M; Laboratory of Microenvironmental Metabolic Health Sciences Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Electronic address: makmurak@m.u-tokyo.ac.jp.
  • Kotani A; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan; Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan. Electronic address: aikotani@k-lab.jp.
Cell Metab ; 34(4): 615-633.e8, 2022 04 05.
Article em En | MEDLINE | ID: mdl-35294862
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Infecções por Vírus Epstein-Barr / Fosfolipases A2 Secretórias / Vesículas Extracelulares / Linfoma Limite: Animals / Humans Idioma: En Revista: Cell Metab Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Infecções por Vírus Epstein-Barr / Fosfolipases A2 Secretórias / Vesículas Extracelulares / Linfoma Limite: Animals / Humans Idioma: En Revista: Cell Metab Ano de publicação: 2022 Tipo de documento: Article